BACE1 inhibitory effects of lavandulyl flavanones from Sophora flavescens

Eun Mi Hwang, Young Bae Ryu, Hoi Young Kim, Dong Gyu Kim, Seong Geun Hong, Jin Hwan Lee, Marcus J. Curtis-Long, Seong Hun Jeong, Jae Yong Park, Ki Hun Park

Research output: Contribution to journalArticlepeer-review

44 Citations (Scopus)


In order to access β-secretase (BACE1), and enzyme strongly implicated in the cause of Alzheimer's disease, inhibitors must possess sufficient lipophilicity to traverse two lipid bilayers. Current drug candidates, which are almost totally peptide-derived, are thus inefficient because cell permeability presents a serious limiting factor. In this study, lipophilic alkylated (C10-C5) flavanones from Sophora flavescens were examined for their inhibitory effects against β-secretase. Lavandulyl flavanones (1, 2, 5, 6, and 8) showed potent β-secretase inhibitory activities with IC50s of 5.2, 3.3, 8.4, 2.6, and 6.7 μM, respectively, while no significant activity was observed in the corresponding hydrated lavandulyl flavanones (4 and 7) and prenylated flavanone (3). As we expected, lavandulyl flavanones reduced Aβ secretion dose-dependently in transfected human embryonic kidney (HEK-293) cells. In kinetic studies, all compounds screened were shown to be noncompetitive inhibitor.

Original languageEnglish
Pages (from-to)6669-6674
Number of pages6
JournalBioorganic and Medicinal Chemistry
Issue number14
Publication statusPublished - 2008 Jul 15
Externally publishedYes


  • Alzheimer's disease
  • BACE1
  • HEK 293
  • Lavandulyl flavanone
  • Sophora flavescens

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry


Dive into the research topics of 'BACE1 inhibitory effects of lavandulyl flavanones from Sophora flavescens'. Together they form a unique fingerprint.

Cite this